MS and Stress: Recalibrating for the HolidaysA Conversation with Patricia Daily, LCSW People with MS frequently say that stress makes their MS symptoms worse, so the question is, does stress…
Read More
Earlier this month, the US Food and Drug Administration (FDA) approved alemtuzumab (Lemtrada, Genzyme, a Sanofi Company) for the treatment of relapsing forms of multiple sclerosis (MS). A company statement…
At the Education Summit, we opened the floor for Q & A for participants to ask questions related to the doctors presentations. The Q & A was recorded and we’ve…
In addition to the Education Summit, the Rocky Mountain MS Center launched a new webinar series featuring Dr. Timothy Vollmer and his presentation on Maximizing Lifelong Brain Health. People from…
In late October, the Rocky Mountain MS Center hosted the 2014 Education Summit in Golden, Colorado. Over 300 people attended from throughout the region to learn about topics including the…
Dr. Miravalle, could you please describe the approach and purpose of the Brain Volume and Tysabri study? The Brain Volume study is for people with MS who have been taking…
Dr. Miravalle, could you please describe the approach and purpose of the Tysabri study? The Brain Volume study is for people with MS who have been taking Tysabri for at…
People experiencing symptoms consistent with secondary-progressive multiple sclerosis may be eligible to participate in a clinical research trial of an investigational therapy, Siponimod. A new Phase III clinical research trial,…
We recently chatted with one of our fantastic volunteers, Matt Tarpey. Matt was born and raised in Denver, Colorado. He was diagnosed with MS in 2008. He’s a big Broncos…